Published in Exp Diabetes Res on February 28, 2012
Inflammatory, metabolic, and genetic mechanisms of vascular calcification. Arterioscler Thromb Vasc Biol (2014) 1.21
Emerging role of circulating calcifying cells in the bone-vascular axis. Circulation (2012) 1.11
Serum osteocalcin level and its association with carotid atherosclerosis in patients with type 2 diabetes. Cardiovasc Diabetol (2013) 0.94
It is all in the blood: the multifaceted contribution of circulating progenitor cells in diabetic complications. Exp Diabetes Res (2012) 0.94
Patients with an HbA1c in the prediabetic and diabetic range have higher numbers of circulating cells with osteogenic and endothelial progenitor cell markers. J Clin Endocrinol Metab (2012) 0.93
Mechanisms of ectopic calcification: implications for diabetic vasculopathy. Cardiovasc Diagn Ther (2015) 0.89
Arterial calcification: Finger-pointing at resident and circulating stem cells. World J Stem Cells (2014) 0.83
Calcifying circulating cells: an uncharted area in the setting of vascular calcification in CKD patients. Clin Kidney J (2016) 0.78
A module of human peripheral blood mononuclear cell transcriptional network containing primitive and differentiation markers is related to specific cardiovascular health variables. PLoS One (2014) 0.76
Innovative Flow Cytometry Allows Accurate Identification of Rare Circulating Cells Involved in Endothelial Dysfunction. PLoS One (2016) 0.75
Suitable bone markers assessing bone status in patients with both coronary artery disease and diabetes. J Diabetes Metab Disord (2016) 0.75
Is chronic kidney disease-mineral and bone disorder associated with the presence of endothelial progenitor cells with a calcifying phenotype? Clin Kidney J (2017) 0.75
High density lipoprotein modulates osteocalcin expression in circulating monocytes: a potential protective mechanism for cardiovascular disease in type 1 diabetes. Cardiovasc Diabetol (2017) 0.75
A new equation to estimate glomerular filtration rate. Ann Intern Med (2009) 71.41
Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care (2003) 20.07
Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res (1999) 11.32
Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation (2004) 4.31
Circulating osteoblast-lineage cells in humans. N Engl J Med (2005) 4.19
Vascular calcification: mechanisms and clinical ramifications. Arterioscler Thromb Vasc Biol (2004) 4.02
Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res (2006) 3.57
Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11. Early Treatment Diabetic Retinopathy Study Research Group. Ophthalmology (1991) 2.77
Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation (2003) 2.63
CD14+CD34low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res (2005) 2.62
Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol (2006) 2.51
Role of beta2-integrins for homing and neovascularization capacity of endothelial progenitor cells. J Exp Med (2004) 2.04
High-mobility group box 1 activates integrin-dependent homing of endothelial progenitor cells. Circ Res (2007) 1.89
Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis (2008) 1.79
Role for circulating osteogenic precursor cells in aortic valvular disease. Arterioscler Thromb Vasc Biol (2011) 1.61
Osteocalcin expression by circulating endothelial progenitor cells in patients with coronary atherosclerosis. J Am Coll Cardiol (2008) 1.55
Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis (2007) 1.44
Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes. Circ Res (2011) 1.41
Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care (2011) 1.37
Mitral valve endothelial cells with osteogenic differentiation potential. Arterioscler Thromb Vasc Biol (2010) 1.31
Significance of endothelial progenitor cells in subjects with diabetes. Diabetes Care (2007) 1.29
Diabetic complications and dysregulated innate immunity. Front Biosci (2008) 1.28
Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Thromb Vasc Biol (2008) 1.27
Medial arterial calcification in diabetes and its relationship to neuropathy. Diabetologia (2009) 1.26
Glucose tolerance is negatively associated with circulating progenitor cell levels. Diabetologia (2007) 1.21
Coronary endothelial dysfunction in humans is associated with coronary retention of osteogenic endothelial progenitor cells. Eur Heart J (2010) 1.11
Differentiation of bone marrow-derived endothelial progenitor cells is shifted into a proinflammatory phenotype by hyperglycemia. Mol Med (2009) 1.04
Interaction between human umbilical vein endothelial cells and human osteoprogenitors triggers pleiotropic effect that may support osteoblastic function. Bone (2008) 1.03
Myofibroblast progenitor cells are increased in number in patients with type 1 diabetes and express less bone morphogenetic protein 6: a novel clue to adverse tissue remodelling? Diabetologia (2006) 1.01
Endothelial progenitor cells and the diabetic paradox. Diabetes Care (2006) 0.99
Endothelial dysfunction: causes and consequences in patients with diabetes mellitus. Diabetes Res Clin Pract (2008) 0.99
The expression of functional Toll-like receptor 4 is associated with proliferation and maintenance of stem cell phenotype in endothelial progenitor cells (EPCs). J Cell Biochem (2010) 0.91
Oxidized low-density lipoprotein and β-glycerophosphate synergistically induce endothelial progenitor cell ossification. Acta Pharmacol Sin (2011) 0.87
Circulating smooth muscle progenitors and atherosclerosis. Trends Cardiovasc Med (2010) 0.84
A role for TGF-beta in transforming endothelial progenitor cells into neointimal smooth muscle cells. Atherosclerosis (2010) 0.82
Circulating endothelial progenitor cells are reduced in peripheral vascular complications of type 2 diabetes mellitus. J Am Coll Cardiol (2005) 3.64
Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results. J Diabetes Sci Technol (2010) 3.48
Fully integrated artificial pancreas in type 1 diabetes: modular closed-loop glucose control maintains near normoglycemia. Diabetes (2012) 3.40
Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. J Am Coll Cardiol (2005) 2.75
Sarcoidosis is a Th1/Th17 multisystem disorder. Thorax (2010) 2.60
Number and function of endothelial progenitor cells as a marker of severity for diabetic vasculopathy. Arterioscler Thromb Vasc Biol (2006) 2.51
Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol (2007) 2.43
Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier. J Diabetes Sci Technol (2009) 2.31
Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas. Diabetes Care (2013) 2.26
Piragliatin (RO4389620), a novel glucokinase activator, lowers plasma glucose both in the postabsorptive state and after a glucose challenge in patients with type 2 diabetes mellitus: a mechanistic study. J Clin Endocrinol Metab (2010) 2.05
Osteoprotegerin inactivation accelerates advanced atherosclerotic lesion progression and calcification in older ApoE-/- mice. Arterioscler Thromb Vasc Biol (2006) 1.86
Technical notes on endothelial progenitor cells: ways to escape from the knowledge plateau. Atherosclerosis (2008) 1.79
Effectiveness of immunoglobulin replacement therapy on clinical outcome in patients with primary antibody deficiencies: results from a multicenter prospective cohort study. J Clin Immunol (2011) 1.78
Increase in carotid intima-media thickness in grade I hypertensive subjects: white-coat versus sustained hypertension. Hypertension (2008) 1.74
Accuracy and reliability of continuous glucose monitoring systems: a head-to-head comparison. Diabetes Technol Ther (2013) 1.71
Atorvastatin reduces macrophage accumulation in atherosclerotic plaques: a comparison of a nonstatin-based regimen in patients undergoing carotid endarterectomy. Stroke (2010) 1.67
Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1. Diabetes (2013) 1.65
The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha. Diabetes Care (2010) 1.60
Pilot studies of wearable outpatient artificial pancreas in type 1 diabetes. Diabetes Care (2012) 1.57
Autologous stem cell therapy for peripheral arterial disease meta-analysis and systematic review of the literature. Atherosclerosis (2009) 1.57
A common haplotype at the CD36 locus is associated with high free fatty acid levels and increased cardiovascular risk in Caucasians. Hum Mol Genet (2004) 1.56
Circulating CD34+ cells, metabolic syndrome, and cardiovascular risk. Eur Heart J (2006) 1.50
Downregulation of the longevity-associated protein sirtuin 1 in insulin resistance and metabolic syndrome: potential biochemical mechanisms. Diabetes (2010) 1.48
Peripheral blood CD34+KDR+ endothelial progenitor cells are determinants of subclinical atherosclerosis in a middle-aged general population. Stroke (2006) 1.47
Rosiglitazone reduces glucose-induced oxidative stress mediated by NAD(P)H oxidase via AMPK-dependent mechanism. Arterioscler Thromb Vasc Biol (2007) 1.44
Endothelial progenitor cells relationships with clinical and biochemical factors in a human model of blunted angiotensin II signaling. Hypertens Res (2011) 1.44
Endothelial progenitor cells in the natural history of atherosclerosis. Atherosclerosis (2007) 1.44
Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes. Diabetes Care (2010) 1.43
Widespread increase in myeloid calcifying cells contributes to ectopic vascular calcification in type 2 diabetes. Circ Res (2011) 1.41
Comments on the article "Effects of vildagliptin twice daily vs. sitagliptin once daily on 24-hour acute glucose fluctuations" by Marfella et al.: (Journal of Diabetes and Its Complications 24 [2010] 79-83). J Diabetes Complications (2011) 1.39
Inflammation and hypertension: the search for a link. Nephrol Dial Transplant (2006) 1.37
Expression and function of KIR and natural cytotoxicity receptors in NK-type lymphoproliferative diseases of granular lymphocytes. Blood (2003) 1.37
Expression and role of CCR6/CCL20 chemokine axis in pulmonary sarcoidosis. J Leukoc Biol (2007) 1.37
Real-time improvement of continuous glucose monitoring accuracy: the smart sensor concept. Diabetes Care (2012) 1.37
Postprandial myocardial perfusion in healthy subjects and in type 2 diabetic patients. Circulation (2005) 1.37
Endothelial dysfunction in diabetes: the role of reparatory mechanisms. Diabetes Care (2011) 1.37
Low CD34+ cell count and metabolic syndrome synergistically increase the risk of adverse outcomes. Atherosclerosis (2009) 1.35
Continuous glucose monitoring accuracy results vary between assessment at home and assessment at the clinical research center. J Diabetes Sci Technol (2012) 1.35
Cardiovascular effects of DPP-4 inhibition: beyond GLP-1. Vascul Pharmacol (2011) 1.34
Day and night closed-loop control in adults with type 1 diabetes: a comparison of two closed-loop algorithms driving continuous subcutaneous insulin infusion versus patient self-management. Diabetes Care (2013) 1.32
Significance of endothelial progenitor cells in subjects with diabetes. Diabetes Care (2007) 1.29
Gender differences in endothelial progenitor cells and cardiovascular risk profile: the role of female estrogens. Arterioscler Thromb Vasc Biol (2008) 1.27
Circulating progenitor cells are reduced in patients with severe lung disease. Stem Cells (2006) 1.25
Genetic variability at the leptin receptor (LEPR) locus is a determinant of plasma fibrinogen and C-reactive protein levels. Atherosclerosis (2006) 1.22
Reduced expression of regulator of G-protein signaling 2 (RGS2) in hypertensive patients increases calcium mobilization and ERK1/2 phosphorylation induced by angiotensin II. J Hypertens (2006) 1.20
Continuous glucose monitoring reveals delayed nocturnal hypoglycemia after intermittent high-intensity exercise in nontrained patients with type 1 diabetes. Diabetes Technol Ther (2010) 1.16
Diabetes impairs stem cell and proangiogenic cell mobilization in humans. Diabetes Care (2012) 1.16
Homeostatic chemokines drive migration of malignant B cells in patients with non-Hodgkin lymphomas. Blood (2004) 1.16
Mechanisms of endothelial dysfunction in obesity. Clin Chim Acta (2005) 1.15
Recurrence of cardiovascular events in patients with type 2 diabetes: epidemiology and risk factors. Diabetes Care (2008) 1.14
Overexpression of tumor necrosis factor (TNF)alpha and TNFalpha receptor I in human viral myocarditis: clinicopathologic correlations. Mod Pathol (2004) 1.13
Incidence and risk factors for stroke in type 2 diabetic patients: the DAI study. Stroke (2007) 1.12
Emerging role of circulating calcifying cells in the bone-vascular axis. Circulation (2012) 1.11
Screening for diabetic retinopathy: 1 and 3 nonmydriatic 45-degree digital fundus photographs vs 7 standard early treatment diabetic retinopathy study fields. Am J Ophthalmol (2009) 1.11
Diabetes induces p66shc gene expression in human peripheral blood mononuclear cells: relationship to oxidative stress. J Clin Endocrinol Metab (2004) 1.11
Brain oxygen utilization is unchanged by hypoglycemia in normal humans: lactate, alanine, and leucine uptake are not sufficient to offset energy deficit. Am J Physiol Endocrinol Metab (2005) 1.10
Independent glucose and weight-reducing effects of Liraglutide in a real-world population of type 2 diabetic outpatients. Acta Diabetol (2013) 1.10
Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis. PLoS One (2010) 1.09
Intrinsic and extrinsic mechanisms contribute to maintain the JAK/STAT pathway aberrantly activated in T-type large granular lymphocyte leukemia. Blood (2013) 1.08
Effects of different insulin regimes on postprandial myocardial perfusion defects in type 2 diabetic patients. Diabetes Care (2006) 1.08
Diabetic gait and posture abnormalities: a biomechanical investigation through three dimensional gait analysis. Clin Biomech (Bristol, Avon) (2009) 1.06